Intratympanic injection of dexamethasone for management of labyrinthitis associated with COVID-19 disease resistant cases

OBJECTIVE: To evaluate the efficacy of mixed oral prednisolone and intratympanic dexamethasone (ITID) injection in labyrinthitis, due to COVID 19. METHODS: Seventy-five post-COVID-19 labyrinthitis patients were included. Those patients were treated with systemic oral prednisolone for two weeks and I...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismaiel, Wael F., Abdelazim, Mohamed H., Wahba, Ashraf A., Alsobky, Mahmoud E., Ibrahim, Ahmed Abdalrhman, Ghanem, Soliman A., Rabaan, Ali A., Ismail, Elshahat I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384350/
https://www.ncbi.nlm.nih.gov/pubmed/35989722
http://dx.doi.org/10.1016/j.amsu.2022.104429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384350/
https://www.ncbi.nlm.nih.gov/pubmed/35989722
http://dx.doi.org/10.1016/j.amsu.2022.104429

Ejemplares similares